Advertisement

Topics

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

2014-08-27 03:27:09 | BioPortfolio

Summary

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

Parkinson's Disease

Intervention

There is no intervention, this is a biorepository.

Location

Scripps Clinic, Torrey Pines
La Jolla
California
United States
92037

Status

Active, not recruiting

Source

Scripps Translational Science Institute

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:27:09-0400

Clinical Trials [1060 Associated Clinical Trials listed on BioPortfolio]

The Biorepository for Scripps Health

The investigators propose to establish a Biorepository of both diseased and normal tissue collected from subjects undergoing surgery for solid tumor resection. In cooperation with the Scr...

Goal-oriented Intervention in Parkinson's Disease

Upper-limb disorders in patients with Parkinson's disease include decreased speed and amplitude of movements, difficulty in sequential tasks, and disrupted execution of fine manipulative h...

Biomarkers of Inherited Cardiovascular Conditions

The National Heart Centre Singapore has recently created a biorepository that is IRB approved for the use in genetic studies: "molecular and imaging studies of cardiovascular health and di...

Brain Fitness in Parkinson's Disease

The purpose of this study is to examine the feasibility and potential effectiveness of a cognitive training program among persons with Parkinson's disease. It is hypothesized that individu...

Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease

The purpose of this dual phase cross-sectional, controlled and prospective, open label, exploratory study is to determine the general characteristics of visuospatial exploration and its ne...

PubMed Articles [17782 Associated PubMed Articles listed on BioPortfolio]

Four Cases of Parkinson Disease Diagnosed During the Postpartum Period.

There is little experience with the effect of pregnancy on Parkinson disease because the number of women with Parkinson disease who are of childbearing age is small. We report four cases beginning dur...

Core elements to understand and improve coping with Parkinson's disease in patients and family carers: a focus group study.

1) To explore the meaning that coping with Parkinson's disease has for patients and family carers; 2) To suggest the components of an intervention focused on enhancing their coping with the disease.

Communication changes in Parkinson's disease.

This review looks at the nature and impact of communication changes in Parkinson's disease, approaches to assessment and directions for intervention. This is especially important since medical and sur...

Motivators and Barriers to Exercise in Parkinson's Disease.

Despite evidence for the benefits of exercise in Parkinson's disease (PD), many patients remain sedentary for undefined reasons.

Neuromuscular rate of force development deficit in Parkinson disease.

Bradykinesia and reduced neuromuscular force exist in Parkinson disease. The interpolated twitch technique has been used to evaluate central versus peripheral manifestations of neuromuscular strength ...

Medical and Biotech [MESH] Definitions

Proteins associated with sporadic or familial cases of PARKINSON DISEASE.

A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8)

A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)

Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

More From BioPortfolio on "The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry"

Quick Search
Advertisement
 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Searches Linking to this Trial